UPS expands in healthcare with Bomi acquisition
08 / 08 / 2022
UPS plans to acquire healthcare logistics provider Bomi Group to expand its temperature-controlled facilities.
The transaction will add temperature-controlled facilities in 14 countries – measuring 390,000 sq m – and nearly 3,000 employees.
“The acquisition will play a key role in the delivery of next-generation pharmaceutical and biologic treatments that increasingly require time-critical and temperature-sensitive logistics,” UPS said.
Bomi said that it has 150 customers worldwide, including players in the medical device, in vitro diagnostics, biomedical and pharmaceutical sectors.
The acquisition of Bomi is part of UPS Healthcare’s expansion of its network and services – including Bomi, UPS Healthcare has doubled its global footprint since 2020.
“As a leading global healthcare logistics company, Bomi enhances our portfolio of services and accelerates our journey to become the number one provider of complex healthcare logistics,” said executive vice president and president of UPS International, Healthcare and Supply Chain Solutions Kate Gutmann.
“UPS Healthcare and Bomi Group employees share similar values and our cultures are firmly rooted in a relentless focus on quality. The combination of our two teams will significantly improve our healthcare customers’ ability to continue to develop and deliver life-saving innovations.”
Key Bomi Group leaders, including chief executive Marco Ruini, will continue in their roles after the transaction closes.
The transaction is expected to close by the end of the year, subject to customary regulatory review and approval. The value and terms of the transaction are not being disclosed at this time.
UPS opens Bengaluru facility and adds intercontinental capacity